ALHC

Alignment Healthcare, Inc.

• PR Newswire·22h ago

  ALHC Investor Notification: Alignment Healthcare Investigated for Securities Fraud on behalf of Investors with Losses after Inflated EBITDA Leads to 16% Stock Drop

• Seeking Alpha·11/03 17:05

  What the midterms mean for managed care

• PR Newswire·11/03 11:03

  ALHC Shareholder Notice: Alignment Healthcare Under Investigation for Potential Securities Fraud over Alleged Misrepresentations to Investors

• Dow Jones·11/02 17:05

  Alignment Healthcare Price Target Cut to $10.00/Share From $12.00 by TD Cowen

• Dow Jones·11/02 17:05

  Alignment Healthcare Is Maintained at Buy by TD Cowen

• TipRanks·11/02 16:42

  Alignment Healthcare (ALHC) Receives a Buy from Leerink Partners

• TipRanks·11/02 12:55

  Alignment Healthcare price target lowered to $10 from $12 at TD Cowen

• TipRanks·10/31 06:00

  CMS Star Rating Downgrade Puts Alignment Healthcare’s Core MA Contract and Future Bonus Revenue at Risk

• Dow Jones·10/31 02:47

  Alignment Healthcare Price Target Cut to $8.00/Share From $9.00 by UBS

• Dow Jones·10/31 02:47

  Alignment Healthcare Is Maintained at Neutral by UBS

• PR Newswire·10/31 02:00

  Alignment Healthcare Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alignment Healthcare, Inc. - ALHC

• TipRanks·10/31 00:06

  Alignment Healthcare Balances Rapid Growth With Cost Strain

• Dow Jones·10/30 23:40

  Alignment Healthcare Is Maintained at Overweight by JP Morgan

• Dow Jones·10/30 23:40

  Alignment Healthcare Price Target Cut to $8.00/Share From $10.00 by JP Morgan

• TipRanks·10/30 18:30

  Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Supernus Pharmaceuticals (SUPN) and Alignment Healthcare (ALHC)